Patents by Inventor Owen M. Rennert

Owen M. Rennert has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD EVOLVED FOR RECOGNITION OF THROMBOPHILIA (MERT)
    Publication number: 20090054256
    Abstract: Methods for predicting an individual's genetic risk for developing venous thrombosis in diverse ethnic populations is disclosed, as are arrays and kits which can be used to practice the method. The method includes screening for mutations, polymorphisms, or both, in at least eight venous thrombosis-related molecules, such as antithrombin III, protein C, protein S, fibrinogen, factor V, prothrombin (factor II), methylenetetrahydrofolate reductase (MTHFR), and angiotensin I-converting enzyme (ACE) molecules which are associated with venous thrombosis.
    Type: Application
    Filed: October 3, 2008
    Publication date: February 26, 2009
    Inventors: CIGDEM F. DOGULU, OWEN M. RENNERT, WAI-YEE CHAN
  • Method Evolved for Recognition and Testing of Age Related Macular Degeneration (Mert-Armd)
    Publication number: 20080255000
    Abstract: Methods for predicting an individual's genetic risk for developing ARMD is disclosed, as are arrays and kits which can be used to practice the method. The method includes screening for mutations and/or polymorphisms in ARMD-associated molecules, such as CFH, LOC387715, BF, C2, ABCR, Fibulin 5, VMD2, TLR4, CX3CR1, CST3, MnSOD, MEHE, paraoxonase, APOE, ELOVL4 and hemicentin-1.
    Type: Application
    Filed: November 2, 2006
    Publication date: October 16, 2008
    Inventors: Cigdem F. Dogulu, Owen M. Rennert, Wai-yee Chan